News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anagenics.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Aussie stocks dive as big miners dig a great hole through Monday
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
Health & Biotech
The ASX stocks hoping to profit from the endless search for an ‘elixir of youth’
Health & Biotech
China’s Silk Road for health and wellness is now even more of a two-way street with Australia
Health & Biotech
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News
Reporting Season Round Up: The good times roll on for COVID beneficiary stocks
Health & Biotech
Check Up: Fundie says ‘buy the dip’ as biotech loses shine amid pandemic rebound
Health & Biotech
ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc
News
ASX Small Cap Lunch Wrap: Who’s teaming up for defence deals today?
News
10 at 10: These ASX stocks are lifting off this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Last Orders: Small caps hit another 12-year high ahead of holiday
Health & Biotech
The health stocks still taking a hit from COVID-19
News
